Author

Robabeh Ghodssighassemabadi

Observed name: Ghodssighassemabadi, Robabeh

Institutions: Inserm, Institut Gustave Roussy

Observed institutions: Inserm, Université Paris-Saclay, Institut Gustave Roussy, Centre international de recherche sur le cancer

OpenAlex ID: A5115745591

The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis

2025 · Richa Shah, Nader Mounir Hanna, et al. · Nature Cancer · 47

5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial

2026 · Sofia Rivera, Robabeh Ghodssighassemabadi, et al. · The Lancet · 8

Prevalence of major depressive disorder in Iranian men from 2011 to 2022; a systematic review and meta-analysis

2025 · Ahmad Hajebi, Ilia Zamani Hajiabadi, et al. · BMC Psychiatry · 1

Works count: 4

Citation count: 56

H-index: 2

I10-index: 1